ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

HALO Halozyme Therapeutics Incorporated

38.61
-0.71 (-1.81%)
Apr 12 2024 - Closed
Delayed by 15 minutes

Halozyme Therapeutics Financial Summary

The current HALO market cap is 4.9B. The company's latest EPS is USD 2.2203 and P/E is 17.39.

Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 208.98M181.5M162.14M221.04M216.03M
Operating Income 63.19M74.51M53.8M94.46M88.28M
Net Income 61.63M57.7M39.62M74.75M81.84M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 195.99M267.59M443.31M660.12M829.25M
Operating Income -67.61M144.26M275.9M267.53M337.57M
Net Income -72.24M129.09M402.71M202.13M281.59M
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 1.86B1.84B1.7B1.81B1.89B
Total Liabilities 1.77B1.67B1.63B1.66B1.64B
Total Equity 96.99M169.8M65.85M151.03M249.18M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 565.87M579.92M1.1B1.84B1.73B
Total Liabilities 474.11M428.88M907.48M1.67B1.65B
Total Equity 91.77M151.05M196.95M169.8M83.81M
Quarter End Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating 157.66M240.11M86.96M153.81M286.22M
Investing -485.26M-487.01M-60.16M-5.17M-88.62M
Financing 356.04M362.37M-164.61M-162.17M-158.07M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -85.42M55.45M299.44M240.11M388.57M
Investing -5.55M78.35M-406.29M-487.01M-96.91M
Financing 153.22M-106.28M77.87M362.37M-407.99M
Market Cap 4.9B
Price to Earnings Ratio 17.39
Price to Sales Ratio 5.91
Price to Cash Ratio 41.38
Price to Book Ratio 58.44
Dividend Yield -

Share Statistics

Shares Outstanding 126.82M
Average Volume (1 week) 1.16M
Average Volume (1 Month) 954.41k
52 Week Change 4.04%
52 Week High 45.00
52 Week Low 29.85
Spread (Intraday) 1.82 (4.55%)

Company Info

Company Name Halozyme Therapeutics Incorporated
Address 1209 orange street
wilmington, delaware 19801
Website https://www.halozyme.com
Industry biological pds,ex diagnstics (2836)

Your Recent History

Delayed Upgrade Clock